Smart Ureteral Reconstruction Using Shape-Adaptive Stents

Abstract

Shape-adaptive stents represent a novel advancement in the management of ureteral injuries and strictures. These stents, engineered to conform dynamically to ureteral anatomy, offer promise for improved outcomes in ureteral reconstruction. This review synthesizes recent evidence regarding their design, mechanism of action, clinical relevance, and potential to transform current reconstructive urology practice. The article discusses epidemiology, pathophysiology, clinical features, diagnostic modalities, traditional and emerging management strategies—including the integration of smart stent technologies—along with guideline recommendations and future perspectives.

Introduction

Ureteral injuries and strictures pose significant clinical challenges, often arising from iatrogenic trauma, urolithiasis, malignancy, or congenital anomalies. Conventional stenting solutions, while effective in many cases, are associated with complications such as migration, encrustation, and patient discomfort due to their rigid and non-conforming nature. The development of shape-adaptive, or smart, ureteral stents aims to address these limitations through biomimetic engineering, responsive materials, and integration of sensor technologies. This review provides an evidence-based overview of the use of smart stents in ureteral reconstruction, focusing on their clinical utility and implications for urological practice.

Epidemiology / Disease Burden

Ureteral injuries, although relatively rare, account for 0.5–2.5% of all genitourinary trauma, with iatrogenic causes now surpassing external trauma due to the rise in pelvic and abdominal surgeries. Ureteral strictures, which may result from chronic inflammation, previous surgical intervention, or malignancy, are responsible for significant morbidity, including recurrent urinary tract infections (UTIs), hydronephrosis, renal impairment, and reduced quality of life. The global prevalence of ureteral strictures is estimated to be approximately 0.1% in the general population, with higher rates in those with previous pelvic procedures or radiation exposure. The disease burden is compounded by the limitations of conventional management, emphasizing the need for innovative solutions.

Pathophysiology

The pathophysiology of ureteral injury and stricture formation involves disruption of the ureteral mucosa and muscularis, leading to inflammation, fibrosis, and eventual narrowing or obstruction of the lumen. Ischemia, infection, and persistent mechanical trauma further exacerbate tissue remodeling and scarring. The healing response is often maladaptive, resulting in compromised ureteral patency. Traditional stents, while restoring luminal continuity, may induce pressure necrosis or fail to provide adequate support in anatomically complex cases. Shape-adaptive stents are designed to mitigate these issues by providing uniform, atraumatic support tailored to the dynamic ureteral environment.

Risk Factors

Risk factors for ureteral injury and stricture include prior pelvic surgery (particularly gynecologic, colorectal, and urologic procedures), pelvic radiation, chronic urinary tract infections, urolithiasis, endometriosis, congenital anomalies, and malignancy. Intraoperative technical difficulties, anatomic variations, and delayed recognition of injury significantly increase the risk of stricture formation. Patient-related factors such as diabetes, poor vascular supply, and immune compromise can also impair healing and predispose to adverse outcomes.

Clinical Features

Clinical presentation varies depending on the severity and location of the ureteral pathology. Acute ureteral injury may manifest as flank pain, hematuria, anuria (in bilateral involvement), or signs of urinary extravasation such as peritonitis and sepsis. Ureteral strictures typically present insidiously with flank pain, recurrent UTIs, progressive hydronephrosis, or declining renal function. In some cases, symptoms may be subtle and detected only through imaging performed for unrelated indications. Persistent lower urinary tract symptoms and unexplained renal dysfunction should prompt evaluation for underlying ureteral disease.

Diagnosis

Diagnosis relies on a combination of clinical suspicion and multimodal imaging. Ultrasonography provides initial assessment of hydronephrosis, while computed tomography (CT) urography and magnetic resonance urography offer detailed anatomical delineation of the ureter and surrounding structures. Retrograde and antegrade pyelography remain gold standards for localization and characterization of strictures. Functional assessment with diuretic renal scintigraphy may be necessary to evaluate renal drainage and split function. Endoscopic evaluation allows direct visualization and biopsy when indicated.

Treatment & Management

Management strategies depend on the site, length, and etiology of the injury or stricture. Temporary stenting, balloon dilation, and endoureterotomy are preferred for short-segment, non-malignant strictures. Surgical reconstruction (ureteroureterostomy, ureteroneocystostomy, ileal ureter replacement) is reserved for extensive or refractory cases. Conventional double-J or pigtail stents have served as the mainstay of non-surgical management but are limited by patient discomfort, encrustation, migration, and the need for frequent exchanges. Shape-adaptive stents, constructed from superelastic alloys or bioresorbable polymers, have been developed to address these challenges by offering conformability, reduced trauma, and the potential for drug elution or sensor integration.

Recent Advances / Emerging Therapies

Recent advances in smart stent technology include the use of nitinol-based and hydrogel-coated stents that expand or contract in response to temperature or hydration, optimizing luminal patency while minimizing mucosal irritation. Some prototypes incorporate biosensors capable of monitoring intraluminal pressure, pH, or early signs of infection, enabling real-time clinical decision-making and personalized care. Early clinical trials have demonstrated reduced encrustation rates, improved patient comfort, and lower stent migration compared to traditional devices. Drug-eluting smart stents delivering anti-fibrotic or antimicrobial agents are under evaluation for their potential to further reduce recurrence and complications.

Guideline Recommendations

Current urological guidelines recognize the importance of individualized management of ureteral injuries and strictures, with a strong emphasis on minimally invasive approaches and preservation of renal function. While traditional stents remain standard in many cases, emerging evidence supports the selective use of shape-adaptive stents in complex or high-risk scenarios. The European Association of Urology (EAU) and American Urological Association (AUA) have called for further research and integration of novel stent technologies, particularly those offering enhanced safety, efficacy, and patient-centric outcomes.

Conclusion

Shape-adaptive stents represent a significant innovation in ureteral reconstruction, offering tailored, responsive support that addresses many of the limitations of conventional stenting. As clinical evidence accumulates, these smart devices are poised to enhance outcomes for patients with ureteral injuries and strictures, reducing complication rates and improving quality of life. Continued interdisciplinary collaboration and translational research will be essential to optimize their design, validate their safety, and establish their place in guideline-driven urological care.